Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Payables (2021 - 2025)

Historic Payables for Core Scientific (CORZ) over the last 5 years, with Q3 2025 value amounting to $212.2 million.

  • Core Scientific's Payables rose 76798.53% to $212.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $212.2 million, marking a year-over-year increase of 76798.53%. This contributed to the annual value of $35.6 million for FY2024, which is 8726.12% down from last year.
  • Latest data reveals that Core Scientific reported Payables of $212.2 million as of Q3 2025, which was up 76798.53% from $215.1 million recorded in Q2 2025.
  • Over the past 5 years, Core Scientific's Payables peaked at $1.0 billion during Q3 2022, and registered a low of $86179.0 during Q1 2021.
  • For the 5-year period, Core Scientific's Payables averaged around $145.9 million, with its median value being $86.0 million (2023).
  • As far as peak fluctuations go, Core Scientific's Payables surged by 14587291.68% in 2022, and later crashed by 8726.12% in 2024.
  • Core Scientific's Payables (Quarter) stood at $87.6 million in 2021, then rose by 2.59% to $89.9 million in 2022, then skyrocketed by 210.52% to $279.1 million in 2023, then tumbled by 87.26% to $35.6 million in 2024, then skyrocketed by 496.76% to $212.2 million in 2025.
  • Its last three reported values are $212.2 million in Q3 2025, $215.1 million for Q2 2025, and $22.5 million during Q1 2025.